Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 152 participants.

Also called NCT02132026

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 152 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02132026
Other papers using this trial's data
  • Artificial Intelligence-Enabled Echocardiography as a Surrogate for Multimodality Aortic Stenosis Imaging: Post Hoc Analysis of a Clinical Trial Circulation. Cardiovascular imaging, 2026-02 DOI, PubMed 41473954, PMC12778975 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Effect of Denosumab or Alendronate on Vascular Calcification: Secondary Analysis of SALTIRE2 Randomized Controlled Trial Journal of the American Heart Association, 2024-09-17 DOI, PubMed 39248270, PMC11935633 In the PMC Open Access subset under CC BY.
  • Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial Circulation, 2021-06-22 DOI, PubMed 33913339, PMC8212878 In the PMC Open Access subset under CC BY.
  • Epicardial adipose tissue, myocardial remodelling and adverse outcomes in asymptomatic aortic stenosis: a post hoc analysis of a randomised controlled trial Heart (British Cardiac Society), 2025-06-26 DOI, PubMed 40050004, PMC12202173 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02132026. Randomized; quadruple masking; primary purpose treatment. Start 2014-11-12 (actual); primary completion 2019-11-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.
Acronym
SALTIRE II
Condition
Calcific Aortic Stenosis
Intervention (Drug)
Denosumab
Intervention (Drug)
Alendronic Acid
Intervention (Drug)
Denosumab Placebo
Intervention (Drug)
Alendronic Acid Placebo
Lead sponsor
University of Edinburgh (class: other)
Collaborator
British Heart Foundation (class: other)
Collaborator
NHS Lothian (class: other government)

Record details

Record id
cardio:ct-nct02132026
Content hash
42d048efe7f3ac090e271abe8dfed362b14d00f4ef7c1e30987b3e7fd221dbba